Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects (Q63807102)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects |
clinical trial |
Statements
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy (English)
0 references
July 2011
0 references
April 2013
0 references
81
0 references
18 year
0 references